PDCD1 and thyrotoxicosis: We encountered a rare case of thyrotoxicosis caused by painless thyroiditis and secondary adrenal insufficiency (AI) occurring simultaneously after the combined use of two ICIs; nivolumab, an anti-PD-1 antibody, and ipilimumab, an anti-CTLA-4 antibody.